Although the 'rule of five' has altered medicinal chemistry for oral small molecule drugs, Chris Lipinski believes that predicting the behavior of newer biologics might not be far off, and optimization of RNA or protein delivery could be the opportunity for the next big breakthrough in computer-based predictions.